CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients

por Lefort, S, Thuleau, A, Kieffer, Y, Sirven, P, Bieche, I, Marangoni, E, Vincent-Salomon, A, Mechta-Grigoriou, F
Publicado 2017

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer

por Faucheux, L., Grandclaudon, M., Perrot-Dockès, M., Sirven, P., Berger, F., Hamy, A.S., Fourchotte, V., Vincent-Salomon, A., Mechta-Grigoriou, F., Reyal, F., Scholer-Dahirel, A., Guillot-Delost, M., Soumelis, V.
Publicado 2019